First Time Loading...

Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN

Watchlist Manager
Biohaven Pharmaceutical Holding Company Ltd Logo
Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
Watchlist
Price: 37.94 USD 3.32% Market Closed
Updated: May 29, 2024

Biohaven Pharmaceutical Holding Company Ltd
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Biohaven Pharmaceutical Holding Company Ltd
Total Receivables Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
Total Receivables
$13.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Receivables
$11.9B
CAGR 3-Years
8%
CAGR 5-Years
16%
CAGR 10-Years
10%
Gilead Sciences Inc
NASDAQ:GILD
Total Receivables
$4.7B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
4%
Amgen Inc
NASDAQ:AMGN
Total Receivables
$6.8B
CAGR 3-Years
15%
CAGR 5-Years
12%
CAGR 10-Years
10%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Receivables
$1.8B
CAGR 3-Years
22%
CAGR 5-Years
33%
CAGR 10-Years
40%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Receivables
$5.2B
CAGR 3-Years
8%
CAGR 5-Years
18%
CAGR 10-Years
17%

See Also

What is Biohaven Pharmaceutical Holding Company Ltd's Total Receivables?
Total Receivables
13.6m USD

Based on the financial report for Dec 31, 2023, Biohaven Pharmaceutical Holding Company Ltd's Total Receivables amounts to 13.6m USD.

What is Biohaven Pharmaceutical Holding Company Ltd's Total Receivables growth rate?
Total Receivables CAGR 1Y
-70%

Over the last year, the Total Receivables growth was -70%.